Sangamo Therapeutics Inc (SGMO) Technical Exchange News May 07, 2025, 19:23 UTC 59 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
PLURI (PLUR) Technical Exchange News May 07, 2025, 19:22 UTC 60 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Palisade Bio Inc. (PALI) Technical Exchange News May 07, 2025, 19:22 UTC 55 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Hyperfine Inc (HYPR) Technical Exchange News May 07, 2025, 19:22 UTC 57 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Estrella Immunopharma Inc. (ESLA) Technical Exchange News May 07, 2025, 19:22 UTC 57 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Seres Therapeutics Inc (MCRB) Technical Exchange News May 07, 2025, 01:53 UTC 63 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Eyenovia Inc. (EYEN) Technical Exchange News May 07, 2025, 01:53 UTC 65 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Seres Therapeutics Inc (MCRB) Technical Exchange News May 06, 2025, 19:18 UTC 61 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Eyenovia Inc. (EYEN) Technical Exchange News May 06, 2025, 19:18 UTC 66 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
cbdMD Inc. (YCBD$A) Technical Exchange News May 06, 2025, 07:48 UTC 62 0 comments cbdMD Inc. (YCBD$A) was removed from the list of traded instruments on NYSE MKT exchange Comment Full text